Home » Product Type » Enzymes » Kinases » MEK » MEK Inhibitor Tocriset™

MEK Inhibitor Tocriset™

Cat. No. 2243

Contents of Tocriset:

Cat.No.	Product Name / Activity
1144	U0126
	potent, selective inhibitor of MEK1 and MEK2
1213	PD 98059
	specific inhibitor of MAPKK/MEK
1969	SL 327
	selective inhibitor of MEK1 and MEK2; brain penetrant

Price and Availability

For MEK Inhibitor Tocriset™ pricing & availability please select your country from the drop down menu:
Submit

By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Biological Activity

Contains the above products which can be used to selectively inhibit MEK signalling. The products are supplied either as a solid (U0126) or pre-dissolved in DMSO at a stock concentration of 10 mM in 0.5 ml.

Technical Data

Tocrisets contain 3-5 ligands supplied as lyophilized solids or pre-dissolved in DMSO at a specified concentration. Lyophilized solids have been freeze-dried (approximately 0.5-2 mg per vial) so that addition of 0.5 or 1 ml of solvent produces a stock concentration of 10 or 5 mM respectively.

Please see individual product listings for specific technical data and certificate of analysis.

Product Data Sheet / Safety Data Sheet

Product Data Sheet: View current batch

Safety Data Sheet: View Safety Data Sheet

References

Please see individual product listings for specific references.

View Related Products by Target

Kinases Ligand Sets MAPK Signaling

MEK Signal Transduction Ligand Sets

Keywords: MEK Inhibitor Tocriset, supplier, MEK, Inhibitor, Tocriset

Quick Order

Find multiple products by catalog number

Cancer Research Guide

Request your free copy

Highlights over 350 products for cancer research. Request a copy or view PDF today.

Kinases Product Listing

Highlights over 350 products for kinase research. Request a copy or view PDF today.

Kinase Inhibitor Toolbox

80 Kinase inhibitors
pre-dissolved in DMSO

Some of the most potent
kinase inhibitors all on one plate

Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.

Pain Research Guide

Reserve your free copy

Highlights over 280 products for Pain research. Reserve copy

MAPK Signaling Review

Written by Elma Zaganjor and Melanie H. Cobb, leading experts. Request a copy or view PDF today.

Calcium Imbalance and Neuroprotective Targets

Written by E. Besancon et al

'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance.

MAPK Pathway

The MAPK family kinases respond to extracellular stimuli such as heat and stress to mediate intracellular signals. View pathway or download PDF today.